AURA
Price
$6.30
Change
+$0.28 (+4.65%)
Updated
Dec 3 closing price
Capitalization
400.07M
117 days until earnings call
Intraday BUY SELL Signals
PLX
Price
$1.72
Change
+$0.05 (+2.99%)
Updated
Dec 3 closing price
Capitalization
138.32M
98 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AURA vs PLX

Header iconAURA vs PLX Comparison
Open Charts AURA vs PLXBanner chart's image
Aura Biosciences
Price$6.30
Change+$0.28 (+4.65%)
Volume$140.92K
Capitalization400.07M
Protalix BioTherapeutics
Price$1.72
Change+$0.05 (+2.99%)
Volume$484.89K
Capitalization138.32M
AURA vs PLX Comparison Chart in %
AURA
Daily Signal:
Gain/Loss:
PLX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AURA vs. PLX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a StrongBuy and PLX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (AURA: $6.02 vs. PLX: $1.67)
Brand notoriety: AURA and PLX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 27% vs. PLX: 43%
Market capitalization -- AURA: $400.07M vs. PLX: $138.32M
AURA [@Biotechnology] is valued at $400.07M. PLX’s [@Biotechnology] market capitalization is $138.32M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 1 FA rating(s) are green whilePLX’s FA Score has 0 green FA rating(s).

  • AURA’s FA Score: 1 green, 4 red.
  • PLX’s FA Score: 0 green, 5 red.
According to our system of comparison, AURA is a better buy in the long-term than PLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 4 TA indicator(s) are bullish while PLX’s TA Score has 5 bullish TA indicator(s).

  • AURA’s TA Score: 4 bullish, 5 bearish.
  • PLX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, PLX is a better buy in the short-term than AURA.

Price Growth

AURA (@Biotechnology) experienced а -1.47% price change this week, while PLX (@Biotechnology) price change was -6.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

AURA is expected to report earnings on Mar 31, 2026.

PLX is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURA($400M) has a higher market cap than PLX($138M). PLX YTD gains are higher at: -11.128 vs. AURA (-26.764). PLX has higher annual earnings (EBITDA): 10.4M vs. AURA (-107.51M). AURA has more cash in the bank: 177M vs. PLX (33.4M). PLX has less debt than AURA: PLX (5.35M) vs AURA (18.1M). PLX has higher revenues than AURA: PLX (61.9M) vs AURA (0).
AURAPLXAURA / PLX
Capitalization400M138M290%
EBITDA-107.51M10.4M-1,034%
Gain YTD-26.764-11.128241%
P/E RatioN/A21.50-
Revenue061.9M-
Total Cash177M33.4M530%
Total Debt18.1M5.35M338%
FUNDAMENTALS RATINGS
PLX: Fundamental Ratings
PLX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
52
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AURAPLX
RSI
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 7 days ago
61%
Stochastic
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 7 days ago
90%
Momentum
ODDS (%)
Bullish Trend 7 days ago
72%
Bearish Trend 7 days ago
78%
MACD
ODDS (%)
Bullish Trend 7 days ago
84%
N/A
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
76%
Bullish Trend 7 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 7 days ago
76%
Bearish Trend 7 days ago
81%
Advances
ODDS (%)
Bullish Trend 7 days ago
77%
Bullish Trend 9 days ago
84%
Declines
ODDS (%)
Bearish Trend 15 days ago
84%
Bearish Trend 15 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 7 days ago
81%
Aroon
ODDS (%)
Bearish Trend 7 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AURA
Daily Signal:
Gain/Loss:
PLX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ESECX29.60N/A
N/A
Eaton Vance Atlanta Capital Sel Eq C
VSOYX47.08N/A
N/A
Victory Sycamore Small Company Opp Y
RAPIX11.57N/A
N/A
Cohen & Steers Real Assets I
WICGX6.60N/A
N/A
William Blair China Growth I
CBGAX15.17N/A
N/A
ClearBridge Global Infrastructure Inc C

AURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AURA has been loosely correlated with NUVL. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if AURA jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURA
1D Price
Change %
AURA100%
-3.06%
NUVL - AURA
48%
Loosely correlated
-1.37%
DSGN - AURA
47%
Loosely correlated
+0.11%
RGNX - AURA
46%
Loosely correlated
-3.10%
IDYA - AURA
46%
Loosely correlated
-1.75%
DYN - AURA
46%
Loosely correlated
-2.96%
More

PLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLX has been loosely correlated with IOVA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if PLX jumps, then IOVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLX
1D Price
Change %
PLX100%
-1.72%
IOVA - PLX
45%
Loosely correlated
-4.48%
ADMA - PLX
34%
Loosely correlated
-0.62%
STOK - PLX
31%
Poorly correlated
-1.00%
ZNTL - PLX
31%
Poorly correlated
-1.82%
AURA - PLX
31%
Poorly correlated
-3.06%
More